Cardeas Pharma: Clinical Trials

2 trials sponsored by Cardeas Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1

Follow Cardeas Pharma: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization
Amikacin Fosfomycin Inhalation Solution, Aerosolized placebo - Pneumonia, Bacterial
Phase 2WithdrawnCardeas Pharma2014-10-012015-11-18
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
Amikacin fosfomycin inhalation solution, Aerosolized placebo - Pneumonia, Bacterial
Phase 2CompletedCardeas Pharma1432013-12-012017-07-02

Conditions studied

Bacterial Infections (2)  ·  Lung Diseases (2)  ·  Pneumonia (2)  ·  Pneumonia, Bacterial (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)

Countries

France (1)  ·  Greece (1)  ·  Hungary (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Bruce Montgomery, M.D. (1)  ·  Marin Kollef, M.D. (1)

Results publications

PMID 27890714